ARQT Shares Experience Surge in Value
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Arcutis Biotherapeutics Inc shares valued at $199,994 were purchased by Heron Patrick J on Mar 04 ’24. At $9.50 per share, Heron Patrick J acquired 21,052 shares. The insider’s holdings grew […]
ARQT stock rated a Buy by Mizuho
In a filing, Arcutis Biotherapeutics Inc revealed its Director Heron Patrick J acquired Company’s shares for reported $0.2 million on Mar 04 ’24. In the deal valued at $9.50 per share,21,052 shares were bought. As a result of this transaction, Heron Patrick J now holds 8,785,284 shares worth roughly $89.61 million. Then, Watanabe Todd Franklin […]
ARQT Shares Experience Decline in Value
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Arcutis Biotherapeutics Inc shares valued at $199,994 were purchased by Heron Patrick J on Mar 04 ’24. At $9.50 per share, Heron Patrick J acquired 21,052 shares. The insider’s holdings grew to 8,785,284 shares worth approximately $108.41 […]
Arcutis Biotherapeutics Inc (ARQT) receives a Buy rating from Mizuho
Arcutis Biotherapeutics Inc’s recently made public that its Director Heron Patrick J acquired Company’s shares for reported $0.2 million on Mar 04 ’24. In the deal valued at $9.50 per share,21,052 shares were bought. As a result of this transaction, Heron Patrick J now holds 8,785,284 shares worth roughly $99.63 million. Then, Watanabe Todd Franklin […]
A company insider recently bought 21,052 shares of Arcutis Biotherapeutics Inc [ARQT]. Should You Buy?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Arcutis Biotherapeutics Inc shares valued at $199,994 were purchased by Heron Patrick J on Mar 04 ’24. At $9.50 per share, Heron Patrick J acquired 21,052 shares. The insider’s holdings grew to 8,785,284 shares […]
Mizuho Upgrades Arcutis Biotherapeutics Inc (ARQT) to a Buy from a Neutral
Arcutis Biotherapeutics Inc’s filing revealed that its Director Heron Patrick J acquired Company’s shares for reported $0.2 million on Mar 04 ’24. In the deal valued at $9.50 per share,21,052 shares were bought. As a result of this transaction, Heron Patrick J now holds 8,785,284 shares worth roughly $81.35 million. Then, Watanabe Todd Franklin sold […]
